nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Lansoprazole—ATP4A—esophageal cancer	0.0646	0.631	CrCbGaD
Thiabendazole—Lansoprazole—CYP1B1—esophageal cancer	0.0293	0.287	CrCbGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0278	0.031	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.0245	0.0272	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.0244	0.0272	CbGpPWpGaD
Thiabendazole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—esophageal cancer	0.0227	0.0252	CbGpPWpGaD
Thiabendazole—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—esophageal cancer	0.021	0.0234	CbGpPWpGaD
Thiabendazole—CYP1A1—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.0206	0.023	CbGpPWpGaD
Thiabendazole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—esophageal cancer	0.0206	0.023	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—esophageal cancer	0.0185	0.0206	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0177	0.0197	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.0172	0.0191	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.0161	0.018	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.0156	0.0174	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.0155	0.0173	CbGpPWpGaD
Thiabendazole—CYP1A1—Estrogen Receptor Pathway—CYP1B1—esophageal cancer	0.0154	0.0171	CbGpPWpGaD
Thiabendazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—esophageal cancer	0.0145	0.0161	CbGpPWpGaD
Thiabendazole—CYP1A1—Xenobiotics—CYP2A6—esophageal cancer	0.0135	0.015	CbGpPWpGaD
Thiabendazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—esophageal cancer	0.0132	0.0147	CbGpPWpGaD
Thiabendazole—CYP1A1—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.013	0.0145	CbGpPWpGaD
Thiabendazole—CYP1A1—Estrogen metabolism—CYP1B1—esophageal cancer	0.0118	0.0132	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—esophageal cancer	0.0118	0.0132	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—NFE2L2—esophageal cancer	0.0114	0.0127	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.011	0.0122	CbGpPWpGaD
Thiabendazole—CYP1A1—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.0105	0.0117	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.0103	0.0115	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—CYP1B1—esophageal cancer	0.0098	0.0109	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.00888	0.00989	CbGpPWpGaD
Thiabendazole—CYP1A2—Xenobiotics—CYP2A6—esophageal cancer	0.00861	0.0096	CbGpPWpGaD
Thiabendazole—Lansoprazole—ABCB1—esophageal cancer	0.00842	0.0823	CrCbGaD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00828	0.00923	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00809	0.00901	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—esophageal cancer	0.00807	0.00899	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—NFE2L2—esophageal cancer	0.00807	0.00899	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00791	0.00881	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00791	0.00881	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00787	0.00877	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00783	0.00872	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00777	0.00865	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen metabolism—CYP1B1—esophageal cancer	0.00755	0.00841	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—ALDH2—esophageal cancer	0.00738	0.00822	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00705	0.00785	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00686	0.00765	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—HMOX1—esophageal cancer	0.00675	0.00752	CbGpPWpGaD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00668	0.00744	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00638	0.00711	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—SOD2—esophageal cancer	0.00632	0.00704	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.00615	0.00685	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.00566	0.00631	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00561	0.00625	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00559	0.00623	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—esophageal cancer	0.00559	0.00623	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.00559	0.00623	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00554	0.00617	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00526	0.00586	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00523	0.00583	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00516	0.00575	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—esophageal cancer	0.00514	0.00573	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—esophageal cancer	0.00514	0.00573	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00502	0.00559	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00499	0.00556	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00495	0.00552	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00484	0.00539	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—ALDH2—esophageal cancer	0.0047	0.00524	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00455	0.00507	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00452	0.00504	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00446	0.00497	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00438	0.00488	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.00436	0.00485	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00431	0.0048	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00425	0.00474	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.0042	0.00467	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—ADH7—esophageal cancer	0.00416	0.00463	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00407	0.00453	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.00392	0.00437	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00374	0.00417	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00367	0.00408	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—ADH1B—esophageal cancer	0.00365	0.00406	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00358	0.00398	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—esophageal cancer	0.00357	0.00397	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.00357	0.00397	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00357	0.00397	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00353	0.00393	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00345	0.00384	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTO1—esophageal cancer	0.00343	0.00383	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP26A1—esophageal cancer	0.00339	0.00378	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00335	0.00373	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00334	0.00372	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00334	0.00372	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTO1—esophageal cancer	0.00315	0.00351	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—GSTO1—esophageal cancer	0.00311	0.00346	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00308	0.00344	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.00307	0.00342	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.0029	0.00323	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00288	0.00321	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00285	0.00317	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—esophageal cancer	0.00278	0.0031	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.00278	0.00309	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00275	0.00306	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00271	0.00302	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00267	0.00298	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GSTT1—esophageal cancer	0.00266	0.00297	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—ADH7—esophageal cancer	0.00265	0.00295	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—ALDH2—esophageal cancer	0.00257	0.00286	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.00252	0.00281	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GSTT1—esophageal cancer	0.00244	0.00272	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2A6—esophageal cancer	0.00242	0.00269	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.00236	0.00263	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00234	0.0026	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—ADH1B—esophageal cancer	0.00233	0.00259	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—PTGS1—esophageal cancer	0.00229	0.00255	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.0022	0.00245	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.0022	0.00245	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP26A1—esophageal cancer	0.00216	0.00241	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00213	0.00237	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.0021	0.00234	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.0021	0.00234	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTO1—esophageal cancer	0.00201	0.00224	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTO1—esophageal cancer	0.00198	0.00221	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.00196	0.00218	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP1B1—esophageal cancer	0.00195	0.00217	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00192	0.00214	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00188	0.00209	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP19A1—esophageal cancer	0.00183	0.00204	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.00183	0.00203	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00181	0.00201	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.00179	0.00199	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00179	0.00199	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.00164	0.00182	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.00161	0.00179	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.00156	0.00174	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.00154	0.00172	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—CREBBP—esophageal cancer	0.00153	0.00171	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.0015	0.00167	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—esophageal cancer	0.0015	0.00167	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.00146	0.00163	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.0014	0.00156	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.00134	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.00134	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00127	0.00141	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.00124	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00122	0.00136	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.0012	0.00133	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.00117	0.0013	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.00116	0.0013	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00115	0.00128	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00114	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.00114	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00111	0.00123	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—EP300—esophageal cancer	0.00104	0.00116	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	0.00103	0.00115	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	0.00102	0.00114	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BLVRB—esophageal cancer	0.000984	0.0011	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC52A3—esophageal cancer	0.000984	0.0011	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000879	0.00098	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC10A2—esophageal cancer	0.000836	0.000932	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA1—esophageal cancer	0.000836	0.000932	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000809	0.000901	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA2—esophageal cancer	0.000765	0.000852	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000748	0.000833	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADH7—esophageal cancer	0.000711	0.000792	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLCE1—esophageal cancer	0.000711	0.000792	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000706	0.000786	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.000704	0.000784	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000703	0.000783	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000627	0.000699	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000627	0.000699	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADH1B—esophageal cancer	0.000624	0.000695	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TYMP—esophageal cancer	0.000596	0.000664	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP26A1—esophageal cancer	0.00058	0.000646	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALOX15—esophageal cancer	0.000565	0.000629	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000561	0.000625	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TPI1—esophageal cancer	0.000539	0.0006	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTO1—esophageal cancer	0.000539	0.0006	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA1—esophageal cancer	0.000533	0.000594	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000533	0.000594	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDOB—esophageal cancer	0.000517	0.000576	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GAPDH—esophageal cancer	0.000497	0.000554	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CRABP1—esophageal cancer	0.000493	0.000549	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA2—esophageal cancer	0.000488	0.000543	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000477	0.000531	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GNG7—esophageal cancer	0.000469	0.000522	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000453	0.000505	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000453	0.000505	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000448	0.000499	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDH2—esophageal cancer	0.000439	0.000489	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTT1—esophageal cancer	0.000418	0.000466	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2A6—esophageal cancer	0.000413	0.00046	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000411	0.000458	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000398	0.000443	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENO1—esophageal cancer	0.000392	0.000436	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS1—esophageal cancer	0.000392	0.000436	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PSME2—esophageal cancer	0.000386	0.00043	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PSME1—esophageal cancer	0.000386	0.00043	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TYMP—esophageal cancer	0.00038	0.000423	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.00037	0.000412	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALOX15—esophageal cancer	0.00036	0.000401	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTO1—esophageal cancer	0.000344	0.000383	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TPI1—esophageal cancer	0.000344	0.000383	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000337	0.000375	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP1B1—esophageal cancer	0.000333	0.000371	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDOB—esophageal cancer	0.000329	0.000367	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GAPDH—esophageal cancer	0.000317	0.000353	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CRABP1—esophageal cancer	0.000314	0.00035	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP19A1—esophageal cancer	0.000313	0.000349	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GNG7—esophageal cancer	0.000299	0.000333	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMOX1—esophageal cancer	0.000286	0.000318	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.00028	0.000312	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDH2—esophageal cancer	0.00028	0.000312	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCB1—esophageal cancer	0.000274	0.000305	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTT1—esophageal cancer	0.000266	0.000297	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2A6—esophageal cancer	0.000263	0.000293	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000262	0.000292	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENO1—esophageal cancer	0.00025	0.000278	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS1—esophageal cancer	0.00025	0.000278	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PSME2—esophageal cancer	0.000246	0.000274	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PSME1—esophageal cancer	0.000246	0.000274	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000215	0.000239	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP1B1—esophageal cancer	0.000212	0.000237	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000207	0.000231	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP19A1—esophageal cancer	0.0002	0.000222	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CREBBP—esophageal cancer	0.000183	0.000204	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMOX1—esophageal cancer	0.000182	0.000203	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000179	0.000199	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCB1—esophageal cancer	0.000175	0.000195	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NOS3—esophageal cancer	0.000164	0.000183	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—esophageal cancer	0.00015	0.000167	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000132	0.000147	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—EP300—esophageal cancer	0.000125	0.000139	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CREBBP—esophageal cancer	0.000117	0.00013	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NOS3—esophageal cancer	0.000105	0.000117	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—esophageal cancer	9.57e-05	0.000107	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CA—esophageal cancer	9.23e-05	0.000103	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—EP300—esophageal cancer	7.96e-05	8.87e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CA—esophageal cancer	5.89e-05	6.56e-05	CbGpPWpGaD
